Andres G. Fernandez

Andres G. Fernandez serves as the Chief Development Officer and member of the Management Board at Nanobots Therapeutics since January 2023, and co-founded the company as a Drug Development Advisor. Andres founded AF Biopharma Consulting in April 2022, providing services as Principal Consultant. In addition, Andres is active with Fundación "la Caixa" as a member of the International Expert Panel and Mentor for CaixaImpulse, and participates in various advisory roles, including the External Advisory Board at Gate2Brain and the International Advisory Board at the Latvian Institute of Organic Synthesis. Previous positions include Chief Scientific Officer at Landsteiner Genmed, Board Member of the Sociedad Española de Farmacología, and various director roles at Ferrer, where leadership spanned R&D Search and Evaluation and innovation in biotechnology. Academic credentials include a PhD in Pharmacology and an MSc in Pharmacy (Biochemistry) from Universitat de Barcelona, complemented by a Programme for Management Development at Esade.